Acceder

Publicaciones - INMUNOLOGÍA E INMUNOTOLERANCIA EN TRASPLANTES Y ENFERMEDADES DE BASE INMUNOLÓGICA

Cargando...
Alfaro R, Gonzalez-Martinez G, Muro-Perez M, Galian JA, Martinez-Banaclocha H, Fernandez-Gonzalez M, Botella C, Moya-Quiles MR, Muro J, Llorente S, Muro M. Advanced in silico drug design strategies for mitigating transplant rejection: a status update. Expert Opin Drug Discov. 2026 Mar 10. doi: 10.1080/17460441.2026.2642965. Online ahead of print. PubMed PMID: 41804282.
AÑO: 2026; IF: 4.9
Lopez Hernandez N, Sanchez Camara S, Moreno Flores MA, Mateos Llosa M, Manso Murcia C, Herrero Gutierrez E, de Gea Garcia JH. Neuron-specific enolase in hypoxic-ischemic encephalopathy after cardiac arrest: Evaluation as a prognostic biomarker and determination of threshold values. Med Intensiva (Engl Ed). 2026 Mar 19:502427. doi: 10.1016/j.medine.2026.502427. Online ahead of print. PubMed PMID: 41862316.
AÑO: 2026
Hita A, Botella C, Galian JA, Gonzalez-Lopez R, Fernandez-Gonzalez M, Alegria-Marcos MJ, Moya-Quiles R, Martinez-Banaclocha H, Muro-Perez M, Muro J, Minguela A, Legaz I, Muro M. Is the HLA System Really Involved in Implantation, Pregnancy, or Abortion of the Fetus?: Strengths, Weaknesses, and Controversial Points. Am J Reprod Immunol. 2026 Aug;96(2):e70309. doi: 10.1111/aji.70309. PubMed PMID: 42599737; PubMed Central PMCID: PMC13475587.
AÑO: 2026; IF: 2.4
Pons-Fuster E, Martinez-Rodriguez R, Gimeno-Arias L, Alcaraz MJ, Moreno M, Gomez JM, Pelaez A, Garcia E, Tomas C, Munoz A, Martinez-Sanchez MV, Ruiz-Lorente I, Ceballos D, Minguela A, Bernal E. HLA-A*03 may confer protection against long COVID through an enhanced immune response. Infect Dis Now. 2025 Mar 17:105057. doi: 10.1016/j.idnow.2025.105057. Online ahead of print. PubMed PMID: 40107360.
AÑO: 2025; IF: 2.2
Fernandez-Gonzalez M, Llorente S, Galian JA, Botella C, Gonzalez-Lopez R, Alegria MJ, Hita A, Moya-Quiles MR, Martinez-Banaclocha H, Muro-Perez M, Muro J, Minguela A, Legaz I, Muro M. Influence and Role of Regulatory B Cells in Organ Transplantation: The State of the Art, Prospects, and Emerging Insights. Antibodies (Basel). 2025 Nov 7;14(4):95. doi: 10.3390/antib14040095. PubMed PMID: 41283510; PubMed Central PMCID: PMC12641717.
AÑO: 2025; IF: 2.7
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

INMUNOLOGÍA E INMUNOTOLERANCIA EN TRASPLANTES Y ENFERMEDADES DE BASE INMUNOLÓGICA